Tourette Syndrome Association Company Profile

16:42 EDT 22nd September 2017 | BioPortfolio

News Articles [1583 Associated News Articles listed on BioPortfolio]

Tourette Syndrome Pipeline Insight, 2017 [Report Updated: 10072017] Prices from USD $1250

DelveInsight's, Tourette Syndrome Pipeline Insights, 2017, report provides comprehensive insights about pipeline drugs across this Tourette Syndrome. The key objective of the report is to establish t...

Tourette Syndrome Epidemiology Insights to 2025 [Report Updated: 10072017] Prices from USD $2950

DelveInsight Tourette Syndrome Epidemiology Forecast To 2025 provides an overview of the epidemiology trends of Tourette Syndrome in seven major markets US, France, Germany, Italy, Spain, UK and Jap...

When is Tourette Syndrome Actually Autism?

THURSDAY, June 22, 2017 -- More than one in five children with Tourette syndrome also tests positive for autism, a new study shows. But it's unlikely that so many children actually have both disorders...

Teva teams with Nuvelution on Tourette syndrome drug

The two companies will develop AUSTEDO (deutetrabenazine) tablets for the treatment of tics associated with Tourette syndrome in pediatric patients in the US.

Genetic gains and losses in Tourette syndrome uncovered

Researchers have identified structural changes in two genes that increase the risk of developing Tourette syndrome, a neurological disorder characterized by involuntary motor and vocal tics.

Tourette syndrome—finally, something to shout about

Tourette syndrome is a mysterious medical curiosity that has puzzled doctors for more than a century. People who have it suffer from tics and other behavioral problems, such as obsessive compulsive tr...

Rare genetic variants found to increase risk for Tourette syndrome

An international research team led by investigators at Massachusetts General Hospital (MGH) and the University of California at Los Angeles (UCLA) - along with their facilitating partner the Tourette ...

Genes increasing risk of Tourette's syndrome discovered for first time

The first genes linked Tourette's syndrome have been identified in the biggest study of the disorder to date...

Drugs and Medications [55 Associated Drugs and Medications listed on BioPortfolio]

Orap [Gate Pharmaceuticals]

ORAP (Pimozide) Tablets

Methylphenidate hydrochloride [Lake Erie Medical DBA Quality Care Products LLC]

Methylphenidate Hydrochloride 20 mg

Cylert® (pemoline)cs-iv [Abbott Laboratories]

CYLERT® (pemoline)CS-IV

Haldol [McNeil Pharmaceuticals]

HALDOL brand ofhaloperidol injection

Haloperidol [Cardinal Health]


PubMed Articles [5295 Associated PubMed Articles listed on BioPortfolio]

Imitation inhibition in children with Tourette syndrome.

Echopraxia, that is, the open and automatic imitation of other peoples' actions, is common in patients with Gilles de la Tourette syndrome, autism spectrum disorder, and also those with frontal lobe l...

Parental age and the risk of obsessive compulsive disorder and Tourette syndrome / chronic tic disorder in a nationwide population-based sample.

Advancing paternal age has been associated with several neuropsychiatric disorders in children. However, there is limited understanding of this association with obsessive compulsive disorder (OCD) and...

Tics and Tourette: a clinical, pathophysiological and etiological review.

Describe developments in the etiological understanding of Tourette syndrome.

Gilles de la Tourette Syndrome: Symptoms, Causes and Therapy.

Gilles de la Tourette syndrome is a chronic neuropsychiatric movement disease with combined motor tics and at least one vocal tic for a minimum period of 1 year. It typically begins in the childhood (...

Short-Term Efficacy of CBD-Enriched Hemp Oil in Girls with Dysautonomic Syndrome after Human Papillomavirus Vaccination.

Cannabidiol (CBD)-based treatments for several diseases, including Tourette's syndrome, multiple sclerosis, epilepsy, movement disorders and glaucoma, are proving to be beneficial and the scientific c...

Clinical Trials [4449 Associated Clinical Trials listed on BioPortfolio]

National Gilles De La Tourette Study Group

Tourette syndrome is rare. In France, about 3000 patients have a severe form of the disease. The aim of this study is to collect clinical characteristics in 200 patients with Tourette synd...

Study of the Neurobiology of Tourette Syndrome and Related Disorders

OBJECTIVES: I. Investigate the pathobiology of Tourette syndrome and related disorders by measuring various compounds of interest in cerebrospinal fluid, plasma, and urine of patients wit...

A Pilot Study Of SD-809 (Deutetrabenazine) In Moderate To Severe Tourette Syndrome (TS)

The purpose of this study is to evaluate safety, tolerability and preliminary efficacy of SD-809 in the treatment of motor and phonic tics of Tourette Syndrome and to evaluate the pharmaco...

Efficacy of a Therapeutic Combination of Dronabinol and PEA for Tourette Syndrome

This is an investigator-initiated proof of concept study with the purpose to examine the safety, tolerability and feasibility of Dronabinol (synthetic Δ9-THC) and PEA for the treatment of...

Apathy in Tourette Syndrome and Changes in Quality of Life

Tourette syndrome is a complex neuropsychological disorder with both motor and vocal tics associated with multiple psychological co-morbidities. Apathy has not been widely studied in patie...

Companies [1380 Associated Companies listed on BioPortfolio]

Tourette Association of America

Founded in 1972, the Tourette Association of America is dedicated to making life better for all individuals affected by Tourette and Tic Disorders. The only nationwide organizatio...

Tourette Syndrome Association

Catalyst Pharmaceutical Partners, Inc.

Catalyst Pharmaceutical Partners, Inc. is a specialty pharmaceutical company focused on the development and commercialization of prescription drugs targeting rare (orphan) neuromu...

Down Syndrome Association of Los Angeles

Who: Down Syndrome Association of Los Angeles (DSALA) with National Down Syndrome Society Buddy Walk® Spokesperson John C. McGinley, Dr. Cox on the ABC’s SCRUBS; Grand Mar...

Research Down Syndrome

Research Down Syndrome (RDS) is a non-profit foundation which funds research at leading institutions directed towards identifying safe and effective biomedical therapies to treat the intellectual diff...

More Information about "Tourette Syndrome Association" on BioPortfolio

We have published hundreds of Tourette Syndrome Association news stories on BioPortfolio along with dozens of Tourette Syndrome Association Clinical Trials and PubMed Articles about Tourette Syndrome Association for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Tourette Syndrome Association Companies in our database. You can also find out about relevant Tourette Syndrome Association Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record